The Kaplan-Meier (KM) plotter indicated that patients with high NEDD4-1 expression exhibit lower survival rates compared to those with low NEDD4-1 expression in highly aggressive BC populations, specifically HER2-positive and TNBC. This evidence concerns the gene ERBB2 and breast cancer.